Day 3

Day 3

MSC -HF Trial: Auto mesenchymal cell transplantation may improve ventricular function in patients with heart failure of ischemic cause

This study is a phase 2, randomized 2:1, double blind, and placebo-controlled included 59 patients with advanced...

solaci - 24 June, 2015

Day 3

ZEUS Trial: Patients with increased risk of bleeding may benefit from eluting stents Zotarolimus

The use of drug-eluting stents versus bare metal stents is controversial in some clinical situations in patients...

solaci - 24 June, 2015

Day 3

NEXT Trial: Biodegradable polymer stent (Nobori) was similar to the permanent polymer stents (Xience / Promus) at 2 years.

This multicenter work from Japanrandomized 3200 patients to receive biodegradable polymer biolimus eluting stent(Nobori) or everolimus-eluting stent...

solaci - 24 June, 2015

Day 3

SIRS Trial: Methylprednisolone does not decrease mortality and increase the risk of stroke in patients undergoing cardiac surgery

Cardiac surgery with cardiopulmonary bypass results in an inflammatory response of the body that is usually associated...

solaci - 24 June, 2015

Day 3

STAMPEDE Trial: Bariatric surgery was superior to optimal medical therapy to glycemic control in obese type 2diabetics

In the short term, bariatric surgery showed improvement in glycemic control of obese type 2 diabetics.This study...

solaci - 24 June, 2015

Day 3

POISE -2: Aspirin before a noncardiac surgery does not reduce the risk of death or myocardial infarction and increased bleeding.

There is great variability in the perioperative administration of aspirin (ASA) in patients undergoing noncardiac surgery, both...

solaci - 24 June, 2015

Day 3

American Registry for percutaneous aortic valve replacement,one-year evolution of nearly 6000 patients

TVT STS / ACC registrywas developed to obtain data from all patients undergoing percutaneous aortic valve replacement...

solaci - 24 June, 2015

Day 3

GIPS -III: Metformin does not improve ejection fraction in non-diabetic patients undergoing primary angioplasty

There are experimental studies suggesting that metformin admin before and during ischemia and reperfusion could help to...

solaci - 24 June, 2015

MSC -HF Trial: Auto mesenchymal cell transplantation may improve ventricular function in patients with heart failure of ischemic cause

ZEUS Trial: Patients with increased risk of bleeding may benefit from eluting stents Zotarolimus

NEXT Trial: Biodegradable polymer stent (Nobori) was similar to the permanent polymer stents (Xience / Promus) at 2 years.

SIRS Trial: Methylprednisolone does not decrease mortality and increase the risk of stroke in patients undergoing cardiac surgery

STAMPEDE Trial: Bariatric surgery was superior to optimal medical therapy to glycemic control in obese type 2diabetics

POISE -2: Aspirin before a noncardiac surgery does not reduce the risk of death or myocardial infarction and increased bleeding.

American Registry for percutaneous aortic valve replacement,one-year evolution of nearly 6000 patients

GIPS -III: Metformin does not improve ejection fraction in non-diabetic patients undergoing primary angioplasty

Últimas Noticias

Percutaneous Closure of Patent Foramen Ovale in Patients Over 60 Years Old With Cryptogenic Stroke: A Safe and Effective Strategy?

Left Atrial Appendage Closure: Implantation Depth Could Determine Thrombosis Risk

Influence of cusp-overlap and three-cusp coplanar techniques on new-onset conduction disturbances after TAVI

Noticias Institucionales

SOLACI granted its scientific endorsement to CITIC 2026

A Look Back at Panamá Sessions 2026

See the Best Moments From 2026 Panamá Sessions

Accesos